Ishiyama, F. Development and validation of a situational social avoidance scale.. Psychological Reports. 1999, 85 (1): 114–120. doi:10.2466/pr0.1999.85.1.114.
Pilling, S; Mayo-Wilson, E; Mavranezouli, I; Kew, K; Taylor, C; Clark, DM; Guideline Development, Group. Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidance.. BMJ (Clinical research ed.). May 22, 2013, 346: f2541. PMID 23697669. doi:10.1136/bmj.f2541.
Blanco, C.; Bragdon, L. B.; Schneier, F. R.; Liebowitz, M. R. The evidence-based pharmacotherapy of social anxiety disorder. The International Journal of Neuropsychopharmacology. 2012, 16 (1): 235–249. PMID 22436306. doi:10.1017/S1461145712000119.
Blanco, C.; Bragdon, L. B.; Schneier, F. R.; Liebowitz, M. R. The evidence-based pharmacotherapy of social anxiety disorder. The International Journal of Neuropsychopharmacology. 2012, 16 (1): 235–249. PMID 22436306. doi:10.1017/S1461145712000119.